Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism AMPK agonists(AMP activated protein kinase agonists), ENO1 inhibitors(enolase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | US | 09 Apr 2024 | |
Triple Negative Breast Cancer | Preclinical | US | 09 Apr 2024 |